Publications by authors named "Robin Whittaker"

Claim this Profile
P
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530.
Tim P Green, Mike Fennell, Robin Whittaker, Jon Curwen, Vivien Jacobs

Mol Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in oncology drug development.
Darren R Hodgson, Robin D Whittaker, Athula Herath, Dereck Amakye, Glen Clack

Mol Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Bernard Barlaam, Peter Ballard, Robert H Bradbury, Richard Ducray, Hervé Germain, Robin D Whittaker

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Peter Ballard, Bernard C Barlaam, Robert H Bradbury, Allan Dishington, Laurent F A Hennequin, Robin Whittaker

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis